Article Details
Retrieved on: 2018-01-18 03:41:15
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
<div>Carmot Therapeutics, Inc., a Berkeley, California-based biotech company dedicated to the discovery and development of innovative therapeutics generated through Chemotype Evolution, secured $15m in financing. The round was led by <b>Horizons Ventures</b> and The Column Group with participation from ...</div>
Article found on:
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here